Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 4 studies | 19% ± 2% | |
dendritic cell | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of DUS3L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1688.80 | 1445 / 1445 | 100% | 18.79 | 183 / 183 |
pancreas | 100% | 1519.83 | 328 / 328 | 100% | 16.06 | 178 / 178 |
uterus | 100% | 2026.11 | 170 / 170 | 100% | 20.59 | 457 / 459 |
thymus | 100% | 2371.11 | 653 / 653 | 100% | 17.64 | 602 / 605 |
ovary | 100% | 2082.82 | 180 / 180 | 99% | 18.07 | 427 / 430 |
stomach | 100% | 1535.70 | 359 / 359 | 99% | 24.16 | 284 / 286 |
prostate | 100% | 2293.13 | 245 / 245 | 99% | 17.79 | 498 / 502 |
skin | 100% | 2385.72 | 1809 / 1809 | 99% | 29.31 | 468 / 472 |
intestine | 100% | 1835.08 | 966 / 966 | 99% | 28.27 | 522 / 527 |
bladder | 100% | 1809.00 | 21 / 21 | 99% | 24.05 | 497 / 504 |
liver | 100% | 1423.62 | 226 / 226 | 98% | 14.06 | 399 / 406 |
kidney | 100% | 1661.78 | 89 / 89 | 98% | 13.76 | 884 / 901 |
brain | 98% | 950.02 | 2576 / 2642 | 100% | 26.25 | 705 / 705 |
adrenal gland | 100% | 1726.59 | 258 / 258 | 97% | 17.17 | 224 / 230 |
lung | 99% | 1489.79 | 575 / 578 | 98% | 18.74 | 1130 / 1155 |
breast | 100% | 1982.14 | 458 / 459 | 97% | 13.83 | 1088 / 1118 |
adipose | 100% | 1697.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 36.50 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.59 | 29 / 29 |
spleen | 100% | 2322.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.03 | 1 / 1 |
blood vessel | 100% | 1231.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1099.70 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 980.37 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 952.32 | 847 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002943 | Biological process | tRNA dihydrouridine synthesis |
GO_0006397 | Biological process | mRNA processing |
GO_0006417 | Biological process | regulation of translation |
GO_0017150 | Molecular function | tRNA dihydrouridine synthase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0005515 | Molecular function | protein binding |
GO_0106414 | Molecular function | mRNA dihydrouridine synthase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | DUS3L |
Protein name | Dihydrouridine synthase 3 like tRNA-dihydrouridine(47) synthase [NAD(P)(+)] (EC 1.3.1.89) tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like) |
Synonyms | |
Description | FUNCTION: Catalyzes the synthesis of dihydrouridine, a modified base, in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs) . Mainly modifies the uridine in position 47 (U47) in the D-loop of most cytoplasmic tRNAs . Also able to mediate the formation of dihydrouridine in some mRNAs, thereby regulating their translation . . |
Accessions | K7ERF2 ENST00000592491.1 Q96G46 ENST00000592468.5 K7EQU9 ENST00000591560.5 K7EJX8 ENST00000309061.12 [Q96G46-1] K7EM42 ENST00000590343.1 ENST00000320699.12 [Q96G46-3] K7ER20 K7EPA4 ENST00000585587.1 ENST00000590110.2 |